A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)
Clinical trial NCT05093933 · COMPLETED
Trial details
- NCT number
- NCT05093933
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-02
- Primary completion
- 2024-11-20
- Enrollment
- 6106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.